Zymergen Inc.

From EverybodyWiki Bios & Wiki

Zymergen Inc.
Traded asNASDAQ: ZY
Founded 📆2013; 9 years ago (2013)
Founders 👔Jed Dean, Josh Hoffman, Zach Serber
Headquarters 🏙️,
Emeryville, California
Area served 🗺️
Key people
Jay Flatley (Chairman & Acting CEO)[1][2]
Steven Chu (Boardmember)[3][4]
Revenue🤑 Increase $19.61 million (2021)[5]
Number of employees
754[6] (2021)
🌐 Websitewww.zymergen.com
📇 Address
📞 telephone

Zymergen is an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research, design, and manufacture genetically modified organisms.


Zymergen was founded in 2013.[7] The company raised $2 million in 2013, $44 million in 2015,[8] $130 million from SoftBank's Vision Fund in 2016,[9] $400 million in 2018,[10] and $300 million in 2020.[11] The company reportedly included DARPA and Fortune 500 companies among its customers by 2016.[12] In 2018, Zymergen acquired fellow biotechnology firm Radiant Genomics.[13]

Zymergen went public in April 2021, but operational problems resulted in a sharp reduction in market capitalization and shareholder lawsuits shortly after.[2] This led to co-founder Josh Hoffman's resignation as CEO and replacement by acting CEO Jay Flatley, who is also currently Zymergen's chairman and Illumina, Inc.'s former CEO.[1]

See also[edit]

  • Ginkgo Bioworks
  • Precigen


  1. 1.0 1.1 Levy, Ari (2021-08-04). "Synthetic biology company Zymergen plunges 68% after saying product revenue will be 'immaterial' in 2022, removing CEO". CNBC. Archived from the original on 2021-08-04. Unknown parameter |url-status= ignored (help)
  2. 2.0 2.1 Feldman, Amy; Au-Yeung, Angel (2021-10-13). "The Inside Story Of How SoftBank-Backed Zymergen Imploded Four Months After Its $3 Billion IPO". Forbes. Archived from the original on 2021-10-13. Unknown parameter |url-status= ignored (help)
  3. "Board of Directors". Zymergen.
  4. "ソフトバンク、米バイオVBに投資". 日本経済新聞 (in 日本語). 2016-10-12. Archived from the original on 2016-10-17. Unknown parameter |url-status= ignored (help)
  5. "Zymergen (ZY) Valuation Measures & Financial Statistics". finance.yahoo.com. 2021-12-27.
  6. "Zymergen Inc. (ZY) Company Profile & Facts - Yahoo Finance". finance.yahoo.com. 2021-12-27.
  7. Buhr, Sarah (2015-06-16). "With $44 Million In Funding, Biotech Startup Zymergen Is Buying Up Robots To Mass Produce Materials From Microbes". TechCrunch. Archived from the original on 2015-06-16. Unknown parameter |url-status= ignored (help)
  8. Terry, Mark (2015-12-02). "What You Need to Know About Zymergen". BioSpace. Archived from the original on 2019-05-01. Unknown parameter |url-status= ignored (help)
  9. Buhr, Sarah (2016-10-10). "Biotech startup Zymergen nabs $130 million from Softbank". TechCrunch. Archived from the original on 2016-10-11. Unknown parameter |url-status= ignored (help)
  10. Loizos, Connie (2018-12-13). "Zymergen lands $400 million more, led by SoftBank Vision Fund, for its genetically altered microbes". TechCrunch. Archived from the original on 2018-12-13. Unknown parameter |url-status= ignored (help)
  11. Schieber, Jonathan (2020-09-09). "Zymergen raised $300 million because synthetic biology is so hot right now". TechCrunch. Archived from the original on 2020-09-09. Unknown parameter |url-status= ignored (help)
  12. Konrad, Alex (2016-10-11). "Why SoftBank Just Led A $130 Million Mega Round Into Zymergen's Microbe-Creating Robots". Forbes. Archived from the original on 2016-10-12. Unknown parameter |url-status= ignored (help)
  13. "Zymergen Acquires Radiant Genomics". Genomeweb. 2018-01-08. Archived from the original on 2019-05-14. Unknown parameter |url-status= ignored (help)

External links[edit]

This article "Zymergen" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Zymergen. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.